Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 170

    1.

    Anthracycline-induced cardiotoxicity.

    Shan K, Lincoff AM, Young JB.

    Ann Intern Med. 1996 Jul 1;125(1):47-58. Review.PMID: 8644988 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

    Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A.

    Health Technol Assess. 2007 Jul;11(27):iii, ix-x, 1-84. Review.PMID: 17610809 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.

    Wiseman LR, Spencer CM.

    Drugs. 1998 Sep;56(3):385-403. Review.PMID: 9777314 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

    Iarussi D, Indolfi P, Casale F, Martino V, Di Tullio MT, Calabrò R.

    Paediatr Drugs. 2005;7(2):67-76. Review.PMID: 15871628 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.

    Jensen BV.

    Semin Oncol. 2006 Jun;33(3 Suppl 8):S15-21. Review.PMID: 16781285 [PubMed - indexed for MEDLINE]Related articles

    7.

    Epidemiology of anthracycline cardiotoxicity in children and adults.

    Grenier MA, Lipshultz SE.

    Semin Oncol. 1998 Aug;25(4 Suppl 10):72-85. Review.PMID: 9768828 [PubMed - indexed for MEDLINE]Related articles

    8.

    Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

    van Dalen EC, van der Pal HJ, Caron HN, Kremer LC.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005008. Review.PMID: 17054232 [PubMed - indexed for MEDLINE]Related articles

    9.

    Exposure to anthracyclines during childhood causes cardiac injury.

    Lipshultz SE.

    Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. Review.PMID: 16781284 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of anthracycline-induced cardiotoxicity in children: the evidence.

    van Dalen EC, Caron HN, Kremer LC.

    Eur J Cancer. 2007 May;43(7):1134-40. Epub 2007 Mar 26. Review.PMID: 17383867 [PubMed - indexed for MEDLINE]Related articles

    11.

    Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.

    Creutzig U, Diekamp S, Zimmermann M, Reinhardt D.

    Pediatr Blood Cancer. 2007 Jun 15;48(7):651-62.PMID: 17183582 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anthracycline cardiotoxicity in long-term survivors of childhood cancer.

    Scully RE, Lipshultz SE.

    Cardiovasc Toxicol. 2007;7(2):122-8. Review.PMID: 17652816 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

    Pai VB, Nahata MC.

    Drug Saf. 2000 Apr;22(4):263-302. Review.PMID: 10789823 [PubMed - indexed for MEDLINE]Related articles

    14.

    Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.

    Elbl L, Hrstkova H, Tomaskova I, Michalek J.

    Support Care Cancer. 2006 Feb;14(2):128-36. Epub 2005 Jul 21.PMID: 16034614 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anthracycline cardiotoxicity.

    Jones RL, Swanton C, Ewer MS.

    Expert Opin Drug Saf. 2006 Nov;5(6):791-809. Review.PMID: 17044806 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cardioprotective interventions for cancer patients receiving anthracyclines.

    van Dalen EC, Caron HN, Dickinson HO, Kremer LC.

    Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003917. Review. Update in: Cochrane Database Syst Rev. 2008;(2):CD003917. PMID: 15674919 [PubMed - indexed for MEDLINE]Related articles

    17.

    N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.

    Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.

    J Pediatr Hematol Oncol. 2007 Jul;29(7):440-4.PMID: 17609620 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anthracycline cardiotoxicity after breast cancer treatment.

    Hershman DL, Shao T.

    Oncology (Williston Park). 2009 Mar;23(3):227-34. Review.PMID: 19418823 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.

    Nagy AC, Tolnay E, Nagykálnai T, Forster T.

    Neoplasma. 2006;53(6):511-7.PMID: 17167721 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pathogenesis of cardiotoxicity induced by anthracyclines.

    Elliott P.

    Semin Oncol. 2006 Jun;33(3 Suppl 8):S2-7. Review.PMID: 16781283 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data